BioLive Wire · AI-collected
HeartBeam Stock Soars on FDA Breakthrough Designation
- HeartBeam stock soared after receiving an FDA breakthrough device designation, according to an Investing.com report.
Published Oct 5Source: Investing.com ↗
Expert articles and reports as a 3-line summary + takeaway